A c.3037G>A mutation in FBN1 gene causing Marfan syndrome with an atypically severe phenotype

Investigacion Clinica
|June 26, 2018
PubMed

Insights

Marfan syndrome, a genetic connective tissue disorder, can cause severe heart and eye problems. Early diagnosis of FBN1 gene mutations is crucial for timely multidisciplinary care and preventing complications.

Area of Science:

  • Genetics
  • Molecular Biology
  • Cardiology

Background:

  • Marfan syndrome is an autosomal dominant connective tissue disorder.
  • It is primarily caused by mutations in the FBN1 gene, encoding fibrillin-1.
  • Fibrillin-1 is essential for microfibril formation and connective tissue integrity.

Observation:

  • A case of Marfan syndrome presented with severe ocular and systemic manifestations, including cardiac anomalies.
  • Clinical diagnosis was confirmed by identifying a specific c.3037G>A mutation in the FBN1 gene.
  • Molecular modeling revealed the mutation's impact on a calcium-dependent epidermal growth factor-like domain of fibrillin-1.

Findings:

  • The identified FBN1 gene mutation (c.3037G>A) is associated with severe Marfan syndrome phenotypes.
  • The mutation disrupts the calcium-dependent structure of a critical fibrillin-1 domain.
  • This disruption affects microfibrillar formation, leading to connective tissue abnormalities.

Implications:

  • Early clinical and molecular diagnosis of Marfan syndrome is vital.
  • Prompt multidisciplinary assessment and monitoring are essential to prevent severe cardiac and ocular complications.
  • Understanding the molecular basis of FBN1 mutations aids in predicting disease severity and guiding management.

Related Concept Videos

Mutation, Gene Flow, and Genetic Drift01:09

Mutation, Gene Flow, and Genetic Drift

In a population that is not at Hardy-Weinberg equilibrium, the frequency of alleles changes over time. Therefore, any deviations from the five conditions of Hardy-Weinberg equilibrium can alter the genetic variation of a given population. Conditions that change the genetic variability of a population include mutations, natural selection, non-random mating, gene flow, and genetic drift (small population size).
64.5K
Mutations01:39

Mutations

Overview
94.6K
Mutations01:35

Mutations

Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
44.6K
Viral Mutations00:36

Viral Mutations

A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
39.9K
Antipsychotic Drugs: Typical and Atypical Agents01:21

Antipsychotic Drugs: Typical and Atypical Agents

Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...
903
Gene Flow02:39

Gene Flow

Gene flow is the transfer of genes among populations, resulting from either the dispersal of gametes or from the migration of individuals.
38.0K